메뉴 건너뛰기




Volumn 24, Issue 2 B, 2004, Pages 821-825

Down-regulation of the Human Tumor Antigen Mucin by Gemcitabine on the Pancreatic Cancer Cell Line Capan-2

Author keywords

Gemcitabine; Mucin; Tumor antigen

Indexed keywords

GEMCITABINE; MUCIN; NUCLEOSIDE ANALOG; TUMOR ANTIGEN;

EID: 2442491053     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (39)
  • 2
    • 0036991860 scopus 로고    scopus 로고
    • Future directions in the treatment of pancreatic cancer
    • Haller DG: Future directions in the treatment of pancreatic cancer. Semin Oncol 29: 31-39, 2002.
    • (2002) Semin Oncol , vol.29 , pp. 31-39
    • Haller, D.G.1
  • 3
    • 0030964122 scopus 로고    scopus 로고
    • Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil
    • Burris H and Storniolo AM: Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer 33: 18-22, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 18-22
    • Burris, H.1    Storniolo, A.M.2
  • 5
    • 0031824267 scopus 로고    scopus 로고
    • The role of gemcitabine in the treatment of other tumours
    • Carmichael J: The role of gemcitabine in the treatment of other tumours. Br J Cancer 78: 21-25, 1998.
    • (1998) Br J Cancer , vol.78 , pp. 21-25
    • Carmichael, J.1
  • 6
    • 0030722875 scopus 로고    scopus 로고
    • Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine
    • Carmichael J: Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. Digestion 58: 503-507, 1997.
    • (1997) Digestion , vol.58 , pp. 503-507
    • Carmichael, J.1
  • 8
    • 0035007441 scopus 로고    scopus 로고
    • Gemcitabine in advanced bladder cancer
    • von der Maase H: Gemcitabine in advanced bladder cancer. Semin Oncol 28: 11-14, 2001.
    • (2001) Semin Oncol , vol.28 , pp. 11-14
    • Von Der Maase, H.1
  • 9
    • 0034886811 scopus 로고    scopus 로고
    • Gemcitabine in ovarian cancer
    • Orlando M and Mandachain M: Gemcitabine in ovarian cancer. Semin Oncol 28: 62-69, 2001.
    • (2001) Semin Oncol , vol.28 , pp. 62-69
    • Orlando, M.1    Mandachain, M.2
  • 10
    • 0033638288 scopus 로고    scopus 로고
    • The role of gemcitabine alone and in combination in the treatment of pancreatic cancer
    • Oettle H, Arnold D, Hempel C and Riess H: The role of gemcitabine alone and in combination in the treatment of pancreatic cancer. Anticancer Drugs 11: 771-786, 2000.
    • (2000) Anticancer Drugs , vol.11 , pp. 771-786
    • Oettle, H.1    Arnold, D.2    Hempel, C.3    Riess, H.4
  • 13
    • 0029805907 scopus 로고    scopus 로고
    • Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine
    • San Antonio Drug Development Team
    • Von Hoff DD: Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development Team. Invest New Drugs 14: 265-270, 1996.
    • (1996) Invest New Drugs , vol.14 , pp. 265-270
    • Von Hoff, D.D.1
  • 14
    • 0031114142 scopus 로고    scopus 로고
    • Preclinical, pharmacologic, and phase I studies of gemcitabine
    • Storniolo AM, Allerheiligen SR and Pearce HL: Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol 24: 72-77, 1997.
    • (1997) Semin Oncol , vol.24 , pp. 72-77
    • Storniolo, A.M.1    Allerheiligen, S.R.2    Pearce, H.L.3
  • 15
    • 0033198464 scopus 로고    scopus 로고
    • Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line
    • Goan YG, Zhou B, Hu E, Mi S and Yen Y: Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line. Cancer Res 59: 4204-4207, 1999.
    • (1999) Cancer Res , vol.59 , pp. 4204-4207
    • Goan, Y.G.1    Zhou, B.2    Hu, E.3    Mi, S.4    Yen, Y.5
  • 16
    • 0033787983 scopus 로고    scopus 로고
    • Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer
    • Kornmann M, Butzer U, Blatter J, Beger HG and Link KH: Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer. Eur J Surg Oncol 26: 583-587, 2000.
    • (2000) Eur J Surg Oncol , vol.26 , pp. 583-587
    • Kornmann, M.1    Butzer, U.2    Blatter, J.3    Beger, H.G.4    Link, K.H.5
  • 17
    • 0025297509 scopus 로고
    • Polypetide core of a human pancreatic tumor mucin antigen
    • Lan MS, Hollingsworth MA and Metzgar RS: Polypetide core of a human pancreatic tumor mucin antigen. Cancer Res 50: 2997-3001, 1990.
    • (1990) Cancer Res , vol.50 , pp. 2997-3001
    • Lan, M.S.1    Hollingsworth, M.A.2    Metzgar, R.S.3
  • 19
    • 0031106545 scopus 로고    scopus 로고
    • Biology, biochemistry and immunology of carcinoma-associated mucins
    • Taylor-Papadimitriou J and Finn OJ: Biology, biochemistry and immunology of carcinoma-associated mucins. Immunol Today 18: 105-107, 1997.
    • (1997) Immunol Today , vol.18 , pp. 105-107
    • Taylor-Papadimitriou, J.1    Finn, O.J.2
  • 20
    • 0026474723 scopus 로고
    • Mucin gene expression in colonic tissues and cell lines
    • Ogata S, Uehara H, Chen A and Itzkowitz SH: Mucin gene expression in colonic tissues and cell lines. Cancer Res 52: 5971-5978, 1992.
    • (1992) Cancer Res , vol.52 , pp. 5971-5978
    • Ogata, S.1    Uehara, H.2    Chen, A.3    Itzkowitz, S.H.4
  • 22
    • 0024454148 scopus 로고
    • Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells
    • Barnd DL, Lan MS, Metzgar RS and Finn OJ: Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86: 7159-7163, 1989.
    • (1989) Proc Natl Acad Sci USA , vol.86 , pp. 7159-7163
    • Barnd, D.L.1    Lan, M.S.2    Metzgar, R.S.3    Finn, O.J.4
  • 23
    • 0027234878 scopus 로고
    • Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides
    • Ioannides CG, Fisk B, Jerome KR, Irimura T, Wharton JT and Finn OJ: Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 151: 3693-3703, 1993.
    • (1993) J Immunol , vol.151 , pp. 3693-3703
    • Ioannides, C.G.1    Fisk, B.2    Jerome, K.R.3    Irimura, T.4    Wharton, J.T.5    Finn, O.J.6
  • 25
    • 0031297362 scopus 로고    scopus 로고
    • Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen
    • Apostolopoulos V, Karanikas V, Haurum JS and McKenzie IF: Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J Immunol 159: 5211-5218, 1997.
    • (1997) J Immunol , vol.159 , pp. 5211-5218
    • Apostolopoulos, V.1    Karanikas, V.2    Haurum, J.S.3    McKenzie, I.F.4
  • 28
    • 0036453668 scopus 로고    scopus 로고
    • Mucin gene (MUC1) transfected dendritic cells as vaccine: Results of a phase I/II clinical trial
    • Pecher G, Haring A, Kaiser L and Thiel E: Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol Immunother 51: 669-673, 2002.
    • (2002) Cancer Immunol Immunother , vol.51 , pp. 669-673
    • Pecher, G.1    Haring, A.2    Kaiser, L.3    Thiel, E.4
  • 29
    • 0034331218 scopus 로고    scopus 로고
    • Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
    • Brossart P, Wirths S, Stuhler G, Reichardt VL, Kanz L and Brugger W: Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96: 3102-3108, 2000.
    • (2000) Blood , vol.96 , pp. 3102-3108
    • Brossart, P.1    Wirths, S.2    Stuhler, G.3    Reichardt, V.L.4    Kanz, L.5    Brugger, W.6
  • 30
    • 0033472707 scopus 로고    scopus 로고
    • Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells
    • Yang SZ, Kohno N, Kondo K, Yokoyama A, Hamada H, Hiwada K and Miyake M: Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Int J Oncol 15: 1109-1115, 1999.
    • (1999) Int J Oncol , vol.15 , pp. 1109-1115
    • Yang, S.Z.1    Kohno, N.2    Kondo, K.3    Yokoyama, A.4    Hamada, H.5    Hiwada, K.6    Miyake, M.7
  • 31
    • 0021061819 scopus 로고
    • Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
    • Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
    • (1983) J Immunol Methods , vol.65 , pp. 55-63
    • Mosmann, T.1
  • 32
    • 0025101209 scopus 로고
    • Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies
    • Xing PX, Reynolds K, Tjandra JJ, Tang XL and McKenzie IF: Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res 50: 89-96, 1990.
    • (1990) Cancer Res , vol.50 , pp. 89-96
    • Xing, P.X.1    Reynolds, K.2    Tjandra, J.J.3    Tang, X.L.4    McKenzie, I.F.5
  • 34
    • 0037089545 scopus 로고    scopus 로고
    • Gemcitabine exerts a selective effect on the humoral immune response: Implications for combination chemo-immunotherapy
    • Nowak AK, Robinson BW and Lake RA: Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Cancer Res 62: 2353-2358, 2002.
    • (2002) Cancer Res , vol.62 , pp. 2353-2358
    • Nowak, A.K.1    Robinson, B.W.2    Lake, R.A.3
  • 35
    • 0031760361 scopus 로고    scopus 로고
    • 2′-2′-d/fluorodeoxycytidine: In vitro effects on cell-mediated immune response
    • Alvino E, Fuggetta MP, Tricarico M and Bonmassar E: 2′-2′ -d/fluorodeoxycytidine: in vitro effects on cell-mediated immune response. Anticancer Res 18: 3597-3602, 1998.
    • (1998) Anticancer Res , vol.18 , pp. 3597-3602
    • Alvino, E.1    Fuggetta, M.P.2    Tricarico, M.3    Bonmassar, E.4
  • 36
    • 0036462584 scopus 로고    scopus 로고
    • Determinants of resistance to 2′,2′-d/fluorodeoxycytidine (gemcitabine)
    • Bergman AM, Pinedo HM and Peters GJ: Determinants of resistance to 2′,2′-d/fluorodeoxycytidine (gemcitabine). Drug Resist Update 5: 19-33, 2002.
    • (2002) Drug Resist Update , vol.5 , pp. 19-33
    • Bergman, A.M.1    Pinedo, H.M.2    Peters, G.J.3
  • 37
    • 0037137849 scopus 로고    scopus 로고
    • Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
    • Cardillo TM, Blumenthal R, Ying Z and Gold DV: Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer. Int J Cancer 97: 386-92, 2002.
    • (2002) Int J Cancer , vol.97 , pp. 386-392
    • Cardillo, T.M.1    Blumenthal, R.2    Ying, Z.3    Gold, D.V.4
  • 39
    • 0033761311 scopus 로고    scopus 로고
    • Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule
    • Satoh S, Hinoda Y, Hayashi T, Burdick MD, Imai K and Hollingsworth MA: Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer 88: 507-518, 2000.
    • (2000) Int J Cancer , vol.88 , pp. 507-518
    • Satoh, S.1    Hinoda, Y.2    Hayashi, T.3    Burdick, M.D.4    Imai, K.5    Hollingsworth, M.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.